ABSTRACT-The Acute Kidney Injury Network (AKIN) group has recently proposed modifications to the risk of renal failure, injury to kidney, failure of kidney function, loss of kidney function, and end-stage renal failure (RIFLE) classification system. The few studies that have compared the two classifications have revealed no substantial differences. This study aimed to compare the AKIN and RIFLE classifications for predicting outcome in critically ill patients. This retrospective study investigated the medical records of 291 critically ill patients who were treated in medical intensive care units of a tertiary care hospital between March 2003 and February 2006. This study compared performance of the RIFLE and AKIN criteria for diagnosing and classifying AKI and for predicting hospital mortality. Overall mortality rate was 60.8% (177/291). Increased mortality was progressive and significant (chi-square for trend; P G 0.001) based on the severity of AKIN and RIFLE classification. Hosmer and Lemeshow goodness-of-fit test results demonstrated good fit in both systems. The AKIN and RIFLE scoring systems displayed good areas under the receiver operating characteristic curves (0.720 T 0.030, P = 0.001; 0.738 T 0.030, P = 0.001, respectively). Compared with RIFLE criteria, this study indicated that AKIN classification does not improve the sensitivity and ability of outcome prediction in critically ill patients.
INTRODUCTION
Acute kidney injury (AKI) is a common and serious complication in critically ill patients. The mortality rate remains high despite improved renal replacement techniques. A possible cause of the high mortality rate is that intensive care unit (ICU) patients tend to be older and more debilitated than before. Pathophysiological factors associated with AKI are also incriminated in the failure of other organs, indicating that AKI is often part of a multiple organ failure syndrome (1, 2) . Before the development of the RIFLE classification (acronym indicating Risk of renal failure, Injury to the kidney, Failure of kidney function, Loss of kidney function, and End-stage renal failure) system, widely varying definitions of AKI limited epidemiologic investigations of incidence and outcomes in critically ill patients (3) . These varying definitions also have generated clinical confusion and complicated comparisons of data between studies (4, 5) . The RIFLE classification was first proposed by the Acute Dialysis Quality Initiative (ADQI) group to standardize acute renal failure study in 2004 (Table 1) (6) . To date, the classification has proven useful not only for unique populations such as cirrhotic patients and those requiring extracorporeal membrane oxygenation for postcardiotomy cardiogenic shock (7, 8) , but also for diagnosing and classifying the severity of AKI in heterogeneous hospitalized patients in wards and ICUs (9Y12).
Recently, the Acute Kidney Injury Network (AKIN) group, which is composed pf nephrologists and intensivists, has proposed modifying the RIFLE criteria. In AKIN stage 1 (analogous to RIFLE-Risk), a smaller change within 48 h in serum creatinine (SCr) greater than 0.3 mg/dL (Q26.2 2mol/L) was suggested as an AKI threshold (Tables 1 and 2 ). Additionally, patients receiving renal replacement therapy were reclassified as AKIN stage 3 (RIFLE-Failure). Finally, the loss and end-stage kidney disease classification were deleted from the RIFLE system. The reason for these changes was to increase the sensitivity of the RIFLE criteria (13) . The few reported studies comparing the two measures have shown little difference between them (14, 15) . Therefore, this retrospective study compared the efficacy of each scoring system in predicting outcome in ICU patients.
MATERIALS AND METHODS

Patient information and data collection
The local institutional review board approved this study and waived the need for informed consent. This investigation was performed in ICUs at a tertiary care referral center in Taiwan. Post hoc analysis of an accumulated database enrolled 291 heterogeneous critically ill patients with septic shock (16), acute respiratory distress syndrome (ARDS) (17) , or hepatic cirrhosis (8) requiring intensive monitoring and/or treatment unavailable elsewhere. The following patients were excluded: pediatric patients (aged e18 years), chronic uremic patients undergoing renal replacement therapy, and patients whose hospital stay was less than 24 h. Readmitted patients were also excluded from this study. The RIFLE, AKIN category, Acute Physiology and Chronic Health Evaluation (APACHE) II (18) , and Sequential Organ Failure Assessment (SOFA) (19) were also evaluated in the study. Records were collected from patients admitted to medical ICUs between March 2003 and February 2006. Retrospectively collected data were the following: demographic information; underlying diseases; AKIN, RIFLE category, APACHE II, and SOFA scores at admission to an ICU; and length of hospitalization. The primary outcome was hospital mortality. Follow-up at 6 months after hospital discharge was performed via a
Definitions
Septic shock was defined according to modified American College of Chest Physicians and Society of Critical Care Medicine consensus criteria (112 patients) (20) . Fifty-seven patients met ARDS criteria defined by the AmericanEuropean consensus conference (21) . Cirrhosis (122 patients) was diagnosed by liver histology or by combined findings of physical, biochemical, and ultrasonographic examination. The worst physiological and biochemical values on day of initial ICU admission were recorded.
The ADQI group first proposed the RIFLE system at the second ADQI Conference in Vicenza, Italy in May 2002. This classification system uses individual criteria for SCr levels and urine output (UO). The criteria resulting in the worst possible classification are used. Patients are classified into three severity categories (risk, injury, and failure) and two clinical outcome categories (loss and end-stage renal disease). Notably, the F component of RIFLE is present even when the increase in SCr is less than 3-fold as long as the subsequent SCr is greater than 4.0 mg/dL (350 2mol/L) in the setting of an acute increase of greater than 0.5 mg/dL (44 2mol/L). In this study, baseline SCr concentration was measured first during hospitalization. The Modification of Diet in Renal Disease formula was applied for 20 patients who were admitted directly to an ICU, and their SCr concentrations at admission were unknown (6) . Patients were classified by RIFLE into risk, injury, or failure categories.
The AKIN classification (13) differs from the RIFLE classification as follows: it reduces the need for baseline creatinine but does require at least two creatinine values within 48 h; AKIN stage 1 is similar to RIFLE-R but includes abrupt (within 48 h) reduction in kidney function (increase in SCr Q0.3 mg/dL); injury and failure are the same as stages 2 and 3, respectively; stage 3 also includes patients who need renal replacement therapy in any stage; two outcome classes, loss and end-stage kidney disease, are omitted. We used a simple model for mortalityVnon-AKI and AKIN stage 0 (0 points); RIFLE-R and AKIN stage 1 (1 point), RIFLE-I and AKIN stage 2 (2 points), and RIFLE-F and AKIN stage 3 (3 points) for day 1 of ICU admission (7, 8) .
Clinical management
Briefly, cirrhosis patients with gastrointestinal bleeding caused by esophageal varices were initially treated with emergency sclerotherapy combined with vasopressin derivatives administration. Patients with peptic ulcer either with active bleeding or clot were treated with injection of sclerosing agents, followed by proton pump inhibitors. Intravenous fluids were administered to all patients depending on their volume status. Blood transfusion was administered according to the criteria of the attending physician or whenever the hemoglobin decreased below 8 g/dL. In all patients, the presence of bacterial infections at admission and their development during hospitalization were investigated with appropriate diagnostic methods and cultures. Patients were then started on appropriate empiric antibiotic therapy intravenously. In patients developing signs of acute renal failure (oliguria and/or increase in serum creatinine), blood volume expansion with packed red blood cells, albumin, and/or artificial plasma expanders was given to improve renal function and increase urine volume. If oliguria persisted after volume depletion had been corrected or excluded, vasoactive agents with or without the addition of a loop diuretic were prescribed. When acute renal failure was severe or progressive and measured to improve renal function had been unsuccessful, renal replacement therapy was performed.
For ARDS patients, the strategy for the ventilation consists of an initial low tidal volume of 6 to 8 mL/kg for either volume-or pressure-controlled ventilation. Mechanical ventilatory adequacy is monitored by arterial blood gas measurements with the ventilator settings changed as needed. Pulse oximetry is used to monitor oxygen saturation, and the FIO 2 is adjusted to maintain pulse oximetric saturation greater than 90% and avoid raising the plateau airway pressure greater than 35 cm of water. The ventilatory rate ranged from 20 to 25/min, peak airway pressure ranged from 26 to 38 cm of water, and peak end-expiratory pressure ranged from 10 to 16 cm of water. The fraction of inspirited oxygen ranged from 0.9 to 1 in all patients.
For sepsis patients, the early goal-directed resuscitation of the septic patient during the first 6 h after recognition; appropriate diagnostic studies to ascertain causative organisms before starting antibiotics; early administration of broadspectrum antibiotic therapy; reassessment of antibiotic therapy with microbiology and clinical data to narrow coverage, when appropriate; a usual 7 to 10 days of antibiotic therapy guided by clinical response; use of crystalloid, colloid resuscitation, and aggressive fluid challenge to restore mean circulating filling pressure; vasopressor preference for norepinephrine and dopamine; avoidance of supranormal oxygen delivery as a goal of therapy; stress-dose steroid therapy for septic shock; targeting a hemoglobin of 7 to 9 g/dL; appropriate use of fresh frozen plasma and platelets; a semirecumbent bed position unless contraindicated; and maintenance of blood glucose G150 mg/dL after initial stabilization.
Statistical analysis
Descriptive statistics were expressed as mean T SE. Primary analysis compared hospital survivors with nonsurvivors. All variables were tested for normal distributions using the Kolmogorov-Smirnov test. The Student t test was applied to compare the means of continuous variables and normally distributed data; otherwise, the Mann-Whitney U test was used. Categorical 248 SHOCK VOL. 33, NO. 3 data were tested using the chi-square test. This study used the chi-square test for trend to assess categorical data associated with RIFLE classification. Finally, risk factors were assessed by univariate analysis. Calibration was assessed using the Hosmer-Lemeshow goodness-of-fit test to compare the number of observed and predicted deaths in risk groups for the entire range of death probabilities. Discrimination was assessed using the area under a receiver operating characteristic curve (AUROC). Areas under receiver operating characteristic curves were compared by a nonparametric approach. The AUROC analysis was also conducted to calculate cutoff values, sensitivity, specificity, and overall correctness. Finally, cutoff points were calculated by acquiring the best Youden index (sensitivity + specificity -1). Cumulative survival curves as a function of time were generated using the Kaplan-Meier approach and compared using the log-rank test. All statistical tests were twotailed; a value of P G 0.05 was considered statistically significant. Data were analyzed using SPSS 12.0 for Windows (SPSS Inc., Chicago, Ill).
RESULTS
Subject characteristics
Between March 2003 and April 2006, 291 ICU patients with septic shock, ARDS, or hepatic cirrhosis were enrolled. Median patient age was 62 years; 204 (70%) were men and 87 (30%) were female. Overall in-hospital mortality was 60.8% (177/291). Table 3 lists patient demographic data, clinical characteristics, and underlying diseases of both survivors and nonsurvivors. In this study, 160 (55%) patients were in sepsis. Thirty-five (12%) patients had underlying cancer, 122 (42%) patients had liver cirrhosis, and 80 (28%) patients had diabetes mellitus.
Hospital mortality and short-term prognosis
In RIFLE classification, hospital mortality was 36.8% (42/114) for non-AKI patients, 63.2% (24/38) for RIFLE-R (risk), 69.2% (36/52) for RIFLE-I (injury), and 86.2% (75/87) for RIFLE-F (failure; chi-square for trend; P G 0.001; Table 4) . A progressive and significant elevation in mortality was correlated with increasing RIFLE classification severity among all patients. Odds ratios for RIFLE criteria were 2.94 (P = 0.006) for RIFLE-R versus non-AKI, 3.86 (P G 0.001) for RIFLE-I versus non-AKI, and 10.71 (P G 0.001) for RIFLE-F versus non-AKI (Table 5) . Hospital mortality differed significantly (P G 0.001) according to less than and greater than Table 3 ). The AKIN classification also correlated with progressive and significant elevation in mortality. Odds ratios for RIFLE criteria were 1.76 (P = 0.097) for stage 1 versus stage 0, 3.07 (P = 0.002) for stage 2 versus stage 0, and 9.50 (P G 0.001) for stage 3 versus stage 0 (Table 5 ). Hospital mortality rates significantly differed (P G 0.001) less than and greater than cutoffs of AKIN stage 0/AKIN stages 1 to 3 for septic shock (41.5% vs. 67.6%), liver cirrhosis (40.6% vs. 82.9%), and ARDS (30% vs. 58.8%). Table 6 shows the goodness of fit, as measured by the Hosmer-Lemeshow chi-square for predicted mortality risk, and the predictive accuracy of the RIFLE category, AKIN classification, APACHE II, and SOFA scores. Calibration of APACHE II and SOFA scores were superior to RIFLE category and AKIN classification. Table 6 To compare the selected cutoff points for predicting hospital mortality, the sensitivity, specificity, and overall correctness of prediction were all determined. All four scoring systems were tested by Youden index (Table 7 ). Hospital mortality rates differed significantly (P G 0.001) less than and greater than cutoffs of non-AKI category of RIFLE classification, AKIN stage 1, 21 APACHE II points, and 9 SOFA points.
Cumulative survival rates differed significantly (P G 0.05) for non-AKI versus RIFLE-R, RIFLE-I, and RIFLE-F (Fig. 1A) . Figure 1B also shows that cumulative survival rates differed significantly (P G 0.05) for stage 0 versus stages 1 to 3 in the AKIN group.
DISCUSSION
This retrospective study included 291 heterogeneous patients with critical illnesses. Overall in-hospital mortality rate was 60.8%, which is consistent with that obtained by previous studies, indicating poor prognosis of ICU patients with septic shock, ARDS, or hepatic cirrhosis. All patients were classified by RIFLE to identify and classify the severity of AKI and to compare its ability to predict hospital outcome in our study population, which, like those in earlier published studies, was composed of homogeneous or heterogeneous patients (2, 7, 8, 11, 16, 17, 22Y31) . The AKIN group aimed to improve the sensitivity and reproducibility of the AKI criteria and defined the AKIN classification. Bagshaw et al. (15) found that AKIN criteria may not improve sensitivity and predictive ability. Lopes et al. (14) later compared both scoring systems and found that AKIN classification had superior sensitivity to AKI but was inferior for outcome prediction in critically ill patients.
In the present study, compared with RIFLE, AKIN criteria identified 7.9% more patients (RIFLE 60.1% vs. AKIN Analytical results in this study demonstrated that both RIFLE and AKIN criteria precisely predicted hospital mortality and short-term prognosis (Fig. 1 ) in this heterogeneous subset of critically ill patients. The RIFLE score had better discriminatory power and overall correctness than the AKIN score. No material differences were noted between RIFLE and AKIN (Tables 6 and 7) . Among RIFLE, AKIN, APACHE II, and SOFA scores, the SOFA score had the highest overall predictive accuracy and discrimination. Lack of extrarenal predictors in RIFLE and AKIN criteria may explain their discriminative inferiority to SOFA.
Despite the promising analytical results obtained in this study, several important limitations should be recognized. First, this retrospective study was performed at a single tertiary-care medical center, which limits generalization of its findings.
Second, the patient group was mainly collected from patients with septic shock, ARDS, or hepatic cirrhosis and were being treated in medical ICUs; these conditions are associated with poor prognosis; thus, the results may not be directly extrapolated to other patient populations. Third, sequential measurement of these scoring systems (e.g. daily, weekly) may reflect the dynamic aspects of clinical diseases, thus providing superior information on mortality risk. Finally, use of predicted mortality as a clinical performance benchmark is limited by factors not directly related to care quality.
CONCLUSION
In summary, although capable of improving the sensitivity of the AKI diagnosis, the AKIN criteria do not improve the ability to predict a short-term outcome such as in-hospital mortality in critically ill patients. Further study of the RIFLE criteria in prospective randomized controlled clinical trials is needed to establish specific interventions for controlling the progression of AKI. 
